Advancing Therapies in the Idiopathic Pulmonary Fibrosis Treatment Market
The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market is positioned for significant growth, with an anticipated market size of USD 3.89 billion in 2024. This figure is projected to ascend to approximately USD 7.963 billion by 2035, showcasing an impressive compound annual growth rate (CAGR) of 6.73%. The surge in market size is indicative of the rising prevalence of IPF and the ongoing...
0 Comments 0 Shares 79 Views 0 Reviews